Denosumab is a RESTRICTED formulary medication.  Denosumab use is restricted to Hem/Onc prescribers and will only be stocked pursuant to an active patient whose insurance requires buy and bill.  White bag is the primary insurance preference for this medication. 

Preferred biosimilar agent for Inpatient use: Xtrenbo (-qbde)

Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).

• Micromedex Drug Information
• FDA Daily Med Package Insert
• Recent Citations via Medline (PubMed)
• WebMD Pill Identifier